Francoise Calvi-Gries

Further involvements

• 15/12/2022

  11:55 – 12:00 5 Min.

  • ePoster Presentation
  • P 123

  Single centre, prospective, observational study methodology to assess the use of GripAble, a rehabilitation device, on patients with upper limb spasticity (ULS) receiving botulinum toxin A (BoNT-A)

   Spasticity, Telerehabilitation and digital tools
• 16/12/2022

  13:35 – 13:40 5 Min.

  • ePoster Presentation
  • P 496

  Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population

   Outcome measurement, Spasticity
• 16/12/2022

  15:30 – 15:35 5 Min.

  • ePoster Presentation
  • P 097

  Which are the most frequently injected muscles in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in routine practice? Baseline data from the AboLiSh study

   Motor neurorehabilitation, Spasticity
• 16/12/2022

  15:30 – 15:35 5 Min.

  • ePoster Presentation
  • P 331

  A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity (PLLS)

   Pediatric neurorehabilitation, Spasticity